Scientist to Watch

Most Recent

image: Jennifer Reed: Metabolism Modeler

Jennifer Reed: Metabolism Modeler

By | February 1, 2013

Assistant Professor, Chemical & Biological Engineering, University of Wisconsin-Madison, Age: 34

0 Comments

image: Philip Low: Sleep Analyzer

Philip Low: Sleep Analyzer

By | January 1, 2013

Founder, Chairman, and CEO, NeuroVigil, Age: 33

2 Comments

image: Neil Bence: Manipulating Degradation

Neil Bence: Manipulating Degradation

By | December 1, 2012

Senior Scientist, Millennium Pharmaceuticals: The Takeda Oncology Company Age: 39

0 Comments

image: Erica Larschan: Hitting Her Targets

Erica Larschan: Hitting Her Targets

By | November 1, 2012

Assistant Professor, Molecular Biology, Cell Biology, & Biochemistry Brown University, Age: 36

1 Comment

image: Tiago Branco: Neuron Whisperer

Tiago Branco: Neuron Whisperer

By | October 1, 2012

Senior Research Fellow, Wolfson Institute for Biomedical Research, University College London, Age: 34

0 Comments

image: Kartik Chandran: Chemistry Kid

Kartik Chandran: Chemistry Kid

By | September 1, 2012

Associate Professor, Department of Microbiology & Immunology, Albert Einstein College of Medicine, Age: 38

0 Comments

image: Megan Carey: Cerebellum Prober

Megan Carey: Cerebellum Prober

By | August 1, 2012

Group Leader, Neuroscience Program, Champalimaud Center for the Unknown, Lisbon, Portugal; HHMI International Early Career Scientist; Age: 38

0 Comments

Daniel Durocher: Change is Good

By | July 1, 2012

Senior Investigator, Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada. Age 40

0 Comments

image: Sohini Ramachandran: Population Tracker

Sohini Ramachandran: Population Tracker

By | June 1, 2012

Assistant Professor, Ecology and Evolutionary Biology, Brown University. Age: 30

1 Comment

Associate Professor, Department of Urology, University of California, San Francisco. Age: 45

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS